• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向T细胞以作用于B细胞:外用吡美莫司成功治疗皮肤浆细胞增多症

Targeting T cells to hit B cells: successful treatment of cutaneous plasmacytosis with topical pimecrolimus.

作者信息

Hafner Christian, Hohenleutner Ulrich, Babilas Philipp, Landthaler Michael, Vogt Thomas

机构信息

Klinik und Poliklinik fur Dermatologie, Universitat Regensburg, Germany.

出版信息

Dermatology. 2006;213(2):163-5. doi: 10.1159/000093860.

DOI:10.1159/000093860
PMID:16902298
Abstract

Cutaneous plasmacytosis is a rare disease predominantly found in Japanese patients. We describe the case of a 75-year-old white female with cutaneous plasmacytosis of the face and involvement of the bone marrow. In contrast to other cases of cutaneous plasmacytosis, the patient revealed hypogammaglobulinemia and elevated levels of free light chains in the urine. Treatment with topical pimecrolimus 1%, which primarily targets T cells, led to almost complete clinical and histological remission of the skin lesions. Our report indicates that the therapeutically induced disappearance of the plasma cells was due to indirect T-cell-mediated effects.

摘要

皮肤浆细胞增多症是一种罕见疾病,主要见于日本患者。我们报告一例75岁白人女性面部皮肤浆细胞增多症伴骨髓受累的病例。与其他皮肤浆细胞增多症病例不同,该患者出现低丙种球蛋白血症及尿中游离轻链水平升高。使用主要作用于T细胞的1%吡美莫司局部治疗,使皮肤病变几乎完全获得临床及组织学缓解。我们的报告表明,治疗诱导的浆细胞消失是由于间接的T细胞介导效应。

相似文献

1
Targeting T cells to hit B cells: successful treatment of cutaneous plasmacytosis with topical pimecrolimus.靶向T细胞以作用于B细胞:外用吡美莫司成功治疗皮肤浆细胞增多症
Dermatology. 2006;213(2):163-5. doi: 10.1159/000093860.
2
Association between exposure to topical tacrolimus or pimecrolimus and cancers.局部使用他克莫司或吡美莫司与癌症的关联性。
Ann Pharmacother. 2009 Dec;43(12):1956-63. doi: 10.1345/aph.1M278. Epub 2009 Nov 10.
3
A case of a primary cutaneous plasmacytoma presenting in adolescence.一例青春期原发性皮肤浆细胞瘤病例。
Am J Dermatopathol. 2012 Jul;34(5):537-40. doi: 10.1097/DAD.0b013e318245955d.
4
Cutaneous mastocytosis: Two pediatric cases treated with topical pimecrolimus.皮肤肥大细胞增多症:两例接受局部用吡美莫司治疗的儿科病例。
Dermatol Online J. 2010 May 15;16(5):8.
5
[[Extramedullary primary cutaneous plasmacytoma. Description of a case] ].
Recenti Prog Med. 2000 Oct;91(10):507-10.
6
Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.吡美莫司可导致特应性皮炎患者的T细胞因凋亡而减少,但不会使朗格汉斯细胞减少。
J Allergy Clin Immunol. 2005 Jun;115(6):1276-83. doi: 10.1016/j.jaci.2005.02.011.
7
Are multicentric Castleman's disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity?伴有皮肤浆细胞增多症和系统性浆细胞增多症的多中心性Castleman病是同一实体吗?
Histopathology. 2006 Nov;49(5):557-8. doi: 10.1111/j.1365-2559.2006.02532.x.
8
[Topical pimecrolimus and tacrolimus and the risk of cancer].[局部用吡美莫司和他克莫司与癌症风险]
Actas Dermosifiliogr. 2007 Jun;98(5):312-7.
9
Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.局部用钙调神经磷酸酶抑制剂的发现及吡美莫司的药理学特性
Int Arch Allergy Immunol. 2006;141(3):199-212. doi: 10.1159/000095289. Epub 2006 Aug 22.
10
Innovative use of topical calcineurin inhibitors.局部钙调磷酸酶抑制剂的创新应用。
Dermatol Clin. 2010 Jul;28(3):535-45. doi: 10.1016/j.det.2010.03.008.

引用本文的文献

1
Cutaneous Plasmacytosis Associated with Ehrlichiosis in an African-American Patient.一名非裔美国患者中与埃立克体病相关的皮肤浆细胞增多症
J Clin Aesthet Dermatol. 2021 Mar;14(3):24-27. Epub 2021 Mar 1.
2
Cutaneous and systemic plasmacytosis on the face: Effective treatment of a case using thalidomide.面部皮肤及系统性浆细胞增多症:使用沙利度胺有效治疗1例
Oncol Lett. 2016 Mar;11(3):1923-1925. doi: 10.3892/ol.2016.4140. Epub 2016 Jan 25.
3
Cutaneous plasmacytosis: a case report and review of pulmonary findings.皮肤浆细胞增多症:一例病例报告及肺部检查结果综述
Dermatol Reports. 2011 Oct 3;3(3):e39. doi: 10.4081/dr.2011.e39. eCollection 2011 Oct 5.
4
Cutaneous plasmacytosis with perineural involvement.伴有神经周围受累的皮肤浆细胞增多症。
Case Rep Dermatol Med. 2014;2014:840845. doi: 10.1155/2014/840845. Epub 2014 Feb 6.
5
The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy.美国食品药品监督管理局(FDA)针对局部用钙调神经磷酸酶抑制剂的“黑框”警告:争议仍在继续。
Drug Saf. 2008;31(3):185-98. doi: 10.2165/00002018-200831030-00001.